LANADELUMAB-FLYO

LANADELUMAB-FLYO was reported 3228 times

LANADELUMAB-FLYO is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ACCESS SITE SCAR 3 0.3333
1 VASCULAR ACCESS SITE COMPLICATION 60 0.2381
2 BLOOD CHOLINESTERASE 1 0.2000
3 COMPLEMENT FACTOR C1 DECREASED 2 0.1667
4 C1 ESTERASE INHIBITOR DECREASED 2 0.1333
5 HEREDITARY ANGIOEDEMA 1217 0.1133
6 BIOPSY LIP 1 0.1000
7 FEAR OF SURGERY 2 0.0870
8 COMPLEMENT DEFICIENCY DISEASE 3 0.0811
9 BODY HEIGHT INCREASED 34 0.0694
10 PERIPHERAL NERVE TRANSPOSITION 2 0.0556
11 BIOPSY COLON 1 0.0417
12 LACK OF INFUSION SITE ROTATION 2 0.0417
13 ADMINISTRATION SITE MASS 1 0.0357
14 BODY HEIGHT ABNORMAL 4 0.0345
15 ALLERGIC PHARYNGITIS 1 0.0294
16 CARDIAC VALVE FIBROELASTOMA 1 0.0256
17 BIOPSY ENDOMETRIUM 1 0.0256
18 PUNCTURE SITE REACTION 2 0.0250
19 LARYNGEAL DISORDER 17 0.0235
20 ADMINISTRATION SITE OEDEMA 2 0.0233
21 CEREBRAL MICROINFARCTION 1 0.0172
22 PUNCTURE SITE PAIN 4 0.0172
23 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 1 0.0169
24 VEIN COLLAPSE 13 0.0169
25 PARATRACHEAL LYMPHADENOPATHY 2 0.0164
26 COMPLEMENT FACTOR C4 DECREASED 3 0.0156
27 APPLICATION SITE CELLULITIS 1 0.0149
28 RESPIRATORY TRACT OEDEMA 11 0.0148
29 CARDIAC DEVICE IMPLANTATION 1 0.0137
30 CENTRAL VENOUS CATHETER REMOVAL 6 0.0128
31 PHARYNGEAL SWELLING 123 0.0126
32 STATUS MIGRAINOSUS 2 0.0124
33 BLOOD CHOLINESTERASE INCREASED 1 0.0116
34 VACCINATION SITE SWELLING 2 0.0116
35 ADMINISTRATION SITE PAIN 13 0.0113
36 ADMINISTRATION SITE INFLAMMATION 1 0.0111
37 LARYNGEAL OBSTRUCTION 2 0.0109
38 BIOPSY LUNG ABNORMAL 1 0.0100
39 FACIAL DISCOMFORT 7 0.0099
40 ALLERGY TO VACCINE 3 0.0097
41 ADMINISTRATION SITE HAEMORRHAGE 1 0.0096
42 BREATH SOUNDS ABSENT 1 0.0091
43 BREAST FEEDING 7 0.0090
44 PTERYGIUM 3 0.0087
45 BLOOD OESTROGEN INCREASED 5 0.0085
46 INJECTION SITE NERVE DAMAGE 2 0.0084
47 PILONIDAL DISEASE 2 0.0083
48 WEIGHT FLUCTUATION 84 0.0080
49 ADMINISTRATION SITE PRURITUS 1 0.0078
50 IMMUNOGLOBULINS ABNORMAL 2 0.0077
51 VASCULAR ACCESS COMPLICATION 6 0.0074
52 BURN OF INTERNAL ORGANS 1 0.0072
53 ALLERGIC RESPIRATORY DISEASE 1 0.0072
54 INSURANCE ISSUE 110 0.0072
55 UTERINE CYST 4 0.0070
56 ADMINISTRATION SITE ERYTHEMA 2 0.0070
57 ERYTHEMA ANNULARE 2 0.0069
58 DISCOURAGEMENT 16 0.0068
59 ENDOSCOPY 4 0.0067
60 LARYNGEAL OEDEMA 40 0.0065
61 VASCULAR COMPRESSION 2 0.0063
62 PHARYNGEAL OPERATION 2 0.0062
63 APPLICATION SITE WOUND 1 0.0061
64 BLOOD IMMUNOGLOBULIN G ABNORMAL 1 0.0060
65 CENTRAL VENOUS CATHETERISATION 18 0.0060
66 CATARACT CONGENITAL 1 0.0059
67 CRANIOFACIAL FRACTURE 5 0.0058
68 STIFF PERSON SYNDROME 2 0.0058
69 ADMINISTRATION SITE BRUISE 2 0.0058
70 RADIAL NERVE PALSY 2 0.0057
71 CERVIX CARCINOMA RECURRENT 1 0.0056
72 MICTURITION FREQUENCY DECREASED 4 0.0053
73 BLOOD INSULIN ABNORMAL 1 0.0053
74 STRESS AT WORK 6 0.0053
75 PRODUCT DISTRIBUTION ISSUE 49 0.0053
76 ANAEMIA FOLATE DEFICIENCY 1 0.0052
77 OESOPHAGEAL INJURY 2 0.0052
78 REPRODUCTIVE TRACT DISORDER 2 0.0050
79 CATHETER SITE INJURY 1 0.0047
80 INFUSION SITE SCAR 2 0.0045
81 ALLERGY TO ARTHROPOD STING 2 0.0044
82 ALLERGY TO PLANTS 2 0.0044
83 GENITAL SWELLING 3 0.0043
84 IMMUNOGLOBULINS INCREASED 2 0.0043
85 MAST CELL ACTIVATION SYNDROME 6 0.0043
86 CANCER IN REMISSION 1 0.0041
87 PRODUCT DOSAGE FORM ISSUE 2 0.0041
88 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
89 ARTIFICIAL CROWN PROCEDURE 2 0.0041
90 BENIGN LUNG NEOPLASM 1 0.0040
91 BRAIN NEOPLASM BENIGN 2 0.0039
92 BREAST DISORDER FEMALE 1 0.0039
93 ACCIDENT AT HOME 2 0.0039
94 PLASMAPHERESIS 2 0.0038
95 IDIOPATHIC URTICARIA 4 0.0037
96 APPLICATION SITE MASS 1 0.0036
97 VEIN RUPTURE 6 0.0036
98 PRODUCT AVAILABILITY ISSUE 79 0.0035
99 LARYNGEAL STENOSIS 2 0.0035
100 VEIN DISORDER 17 0.0034
101 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
102 BIOPSY BREAST 1 0.0032
103 POOR VENOUS ACCESS 33 0.0032
104 BED REST 1 0.0032
105 ADNEXAL TORSION 1 0.0032
106 OEDEMA GENITAL 2 0.0031
107 PHARYNGEAL DISORDER 9 0.0031
108 PHYSICAL DECONDITIONING 8 0.0031
109 ADMINISTRATION SITE SWELLING 1 0.0031
110 CATHETER SITE BRUISE 1 0.0030
111 POSTOPERATIVE ADHESION 2 0.0030
112 ANIMAL BITE 8 0.0030
113 BODY HEIGHT DECREASED 32 0.0030
114 INFUSION SITE URTICARIA 2 0.0030
115 MATERNAL EXPOSURE DURING BREAST FEEDING 12 0.0030
116 BOREDOM 1 0.0029
117 CAROTID ARTERY ANEURYSM 1 0.0029
118 PELVIC FLUID COLLECTION 2 0.0028
119 INFUSION SITE INFLAMMATION 2 0.0028
120 IMMUNISATION REACTION 2 0.0028
121 BITE 2 0.0028
122 ANKLE ARTHROPLASTY 1 0.0028
123 SUSPECTED COVID-19 9 0.0027
124 VASCULAR DEVICE INFECTION 12 0.0026
125 GASTROINTESTINAL BACTERIAL INFECTION 3 0.0026
126 CUTANEOUS LUPUS ERYTHEMATOSUS 5 0.0026
127 STOMACH MASS 2 0.0025
128 HEAT EXHAUSTION 2 0.0025
129 ABDOMINAL SYMPTOM 2 0.0025
130 HAEMATOLOGICAL INFECTION 6 0.0025
131 ALLERGY TO CHEMICALS 3 0.0024
132 COVID-19 IMMUNISATION 2 0.0024
133 BONE SCAN ABNORMAL 1 0.0024
134 MYCOTIC ALLERGY 2 0.0023
135 CARBON MONOXIDE POISONING 1 0.0023
136 INFUSION SITE BRUISING 5 0.0023
137 WISDOM TEETH REMOVAL 3 0.0023
138 BLADDER HYPERTROPHY 1 0.0023
139 MOUTH SWELLING 13 0.0023
140 FEAR OF DISEASE 4 0.0022
141 BONE CONTUSION 2 0.0022
142 DENTAL CARE 4 0.0022
143 TRACHEOSTOMY 3 0.0021
144 HYPERVIGILANCE 2 0.0021
145 ANIMAL SCRATCH 2 0.0021
146 APPLICATION SITE BRUISE 2 0.0021
147 DEVICE RELATED THROMBOSIS 2 0.0020
148 DENTAL OPERATION 5 0.0020
149 AGE-RELATED MACULAR DEGENERATION 3 0.0020
150 CORONAVIRUS TEST POSITIVE 2 0.0019
151 FOOD ALLERGY 15 0.0019
152 CHEST INJURY 4 0.0019
153 ABDOMINAL INJURY 1 0.0019
154 MULTIPLE ALLERGIES 15 0.0019
155 FUNGAEMIA 3 0.0019
156 FACE INJURY 7 0.0018
157 INFUSION SITE MASS 2 0.0018
158 POST PROCEDURAL SWELLING 2 0.0018
159 ARTHROPOD STING 3 0.0018
160 INTENTIONAL PRODUCT USE ISSUE 157 0.0018
161 BURNING MOUTH SYNDROME 1 0.0018
162 SEASONAL ALLERGY 25 0.0018
163 METABOLIC SURGERY 2 0.0018
164 INJECTION SITE SCAR 5 0.0018
165 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
166 CORTISOL DECREASED 2 0.0017
167 MILIARIA 3 0.0017
168 TREATMENT DELAYED 3 0.0017
169 INFUSION SITE PAIN 22 0.0017
170 PREGNANCY 34 0.0017
171 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
172 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
173 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
174 TREATMENT NONCOMPLIANCE 92 0.0017
175 INTRA-ABDOMINAL FLUID COLLECTION 3 0.0017
176 RECTAL PROLAPSE 2 0.0017
177 ALLERGY TO METALS 1 0.0016
178 VULVOVAGINAL SWELLING 3 0.0016
179 PRODUCT PRESCRIBING ERROR 39 0.0016
180 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
181 OVARIAN CYST RUPTURED 2 0.0016
182 GESTATIONAL HYPERTENSION 2 0.0015
183 ADJUSTMENT DISORDER 2 0.0015
184 ABDOMINAL MASS 4 0.0015
185 DEVICE RELATED SEPSIS 3 0.0015
186 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
187 NONSPECIFIC REACTION 8 0.0015
188 COMPLICATION ASSOCIATED WITH DEVICE 21 0.0014
189 OROPHARYNGEAL DISCOMFORT 13 0.0014
190 PHYSICAL ASSAULT 3 0.0014
191 ENDOTRACHEAL INTUBATION 4 0.0014
192 POST HERPETIC NEURALGIA 2 0.0014
193 CARDIAC SEPTAL DEFECT 1 0.0014
194 NONINFECTIVE GINGIVITIS 2 0.0014
195 ACUTE ABDOMEN 2 0.0014
196 GENITAL PAIN 2 0.0014
197 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
198 TONSILLITIS 7 0.0013
199 CARDIAC INFECTION 1 0.0013
200 SENSITIVITY TO WEATHER CHANGE 7 0.0013
201 FOOD POISONING 7 0.0013
202 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 8 0.0013
203 MENOPAUSAL SYMPTOMS 3 0.0013
204 INFUSION SITE PRURITUS 4 0.0013
205 ORAL DISORDER 9 0.0012
206 HEAVY MENSTRUAL BLEEDING 11 0.0012
207 LIGAMENT SPRAIN 12 0.0012
208 GASTROINTESTINAL TUBE INSERTION 3 0.0012
209 LIMB INJURY 32 0.0012
210 MENOPAUSE 3 0.0012
211 INJECTION SITE OEDEMA 2 0.0012
212 CEREBELLAR ATROPHY 1 0.0011
213 DEPRESSIVE SYMPTOM 4 0.0011
214 ABDOMINAL NEOPLASM 1 0.0011
215 THERAPY CHANGE 11 0.0011
216 PRODUCT TAMPERING 2 0.0011
217 CATHETER MANAGEMENT 1 0.0011
218 INABILITY TO AFFORD MEDICATION 11 0.0011
219 WEIGHT INCREASED 245 0.0011
220 BODY TEMPERATURE ABNORMAL 2 0.0011
221 PRESCRIBED OVERDOSE 21 0.0011
222 CATHETER PLACEMENT 2 0.0011
223 ADENOCARCINOMA GASTRIC 1 0.0011
224 FEELING OF DESPAIR 5 0.0011
225 UMBILICAL HERNIA 5 0.0011
226 LIP DISORDER 2 0.0011
227 RESPIRATORY SYMPTOM 3 0.0011
228 ARNOLD-CHIARI MALFORMATION 1 0.0010
229 HEPATIC MASS 2 0.0010
230 PULMONARY PAIN 3 0.0010
231 INJECTION SITE URTICARIA 25 0.0010
232 UNDERWEIGHT 2 0.0010
233 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
234 OBSTRUCTION 4 0.0010
235 RHINITIS 8 0.0010
236 EMERGENCY CARE 3 0.0010
237 ARTHRODESIS 1 0.0010
238 BREAST DISORDER 2 0.0010
239 TEMPERATURE INTOLERANCE 10 0.0010
240 FAMILY STRESS 3 0.0010
241 DEVICE CONNECTION ISSUE 2 0.0009
242 SLEEP DEFICIT 2 0.0009
243 EAR SWELLING 2 0.0009
244 ARTHROPOD BITE 7 0.0009
245 MUSCLE FATIGUE 4 0.0009
246 RENAL NEOPLASM 2 0.0009
247 ALLERGY TO ANIMAL 1 0.0009
248 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 169 0.0009
249 PRODUCT DISPENSING ISSUE 4 0.0009
250 HORDEOLUM 4 0.0009
251 SKIN LACERATION 10 0.0009
252 PRODUCT PRESCRIBING ISSUE 20 0.0009
253 CORONAVIRUS INFECTION 6 0.0009
254 ACCIDENT AT WORK 2 0.0009
255 CONCUSSION 7 0.0009
256 EXPIRED PRODUCT ADMINISTERED 30 0.0009
257 PRODUCT DOSE OMISSION ISSUE 265 0.0009
258 LYME DISEASE 3 0.0009
259 SMALL INTESTINE CARCINOMA 2 0.0009
260 FACIAL PAIN 8 0.0009
261 INFECTIOUS MONONUCLEOSIS 2 0.0009
262 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 3 0.0009
263 CATHETER SITE DISCHARGE 1 0.0009
264 FEAR OF DEATH 2 0.0009
265 GASTRIC POLYPS 2 0.0009
266 DIABETIC RETINOPATHY 3 0.0009
267 ARTERIAL HAEMORRHAGE 1 0.0009
268 FRUSTRATION TOLERANCE DECREASED 7 0.0009
269 UTERINE DISORDER 2 0.0009
270 PRODUCT USE ISSUE 161 0.0009
271 WEIGHT DECREASED 238 0.0009
272 CONTRAST MEDIA REACTION 2 0.0008
273 INGROWING NAIL 2 0.0008
274 THERMAL BURN 6 0.0008
275 ABDOMINAL DISTENSION 88 0.0008
276 WEIGHT ABNORMAL 2 0.0008
277 GASTROINTESTINAL OBSTRUCTION 2 0.0008
278 INFUSION SITE ERYTHEMA 7 0.0008
279 PAINFUL RESPIRATION 2 0.0008
280 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
281 ILLNESS 84 0.0008
282 KIDNEY INFECTION 16 0.0008
283 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
284 FOOT OPERATION 4 0.0008
285 BLADDER DISCOMFORT 1 0.0008
286 OVARIAN CYST 8 0.0008
287 CATHETER SITE INFECTION 3 0.0008
288 ENDODONTIC PROCEDURE 2 0.0008
289 TONGUE OEDEMA 3 0.0008
290 BOWEL MOVEMENT IRREGULARITY 6 0.0008
291 ABDOMINAL INFECTION 2 0.0008
292 ADNEXA UTERI PAIN 1 0.0008
293 LACTOSE INTOLERANCE 2 0.0008
294 DEVICE RELATED INFECTION 12 0.0008
295 PRODUCT TEMPERATURE EXCURSION ISSUE 4 0.0008
296 LIPOMA 2 0.0008
297 CATHETER SITE PAIN 2 0.0008
298 ABDOMINAL OPERATION 1 0.0008
299 PRODUCT PREPARATION ISSUE 5 0.0008
300 INFLUENZA 85 0.0008
301 DYSMENORRHOEA 10 0.0008
302 NASAL DISORDER 2 0.0008
303 INTRACRANIAL ANEURYSM 3 0.0007
304 POST-TRAUMATIC STRESS DISORDER 5 0.0007
305 GASTROINTESTINAL INJURY 2 0.0007
306 NEPHROLITHIASIS 34 0.0007
307 TRIGGER FINGER 3 0.0007
308 CARBON DIOXIDE INCREASED 1 0.0007
309 CALCULUS BLADDER 1 0.0007
310 MENSTRUAL DISORDER 6 0.0007
311 SWELLING FACE 47 0.0007
312 CHOLECYSTITIS INFECTIVE 2 0.0007
313 GASTROENTERITIS VIRAL 13 0.0007
314 INTERMENSTRUAL BLEEDING 4 0.0007
315 INJECTION SITE IRRITATION 9 0.0007
316 SWELLING 66 0.0007
317 BREAST CANCER STAGE IV 2 0.0007
318 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
319 SWOLLEN TONGUE 22 0.0007
320 GASTROINTESTINAL DISORDER 63 0.0007
321 SHOULDER OPERATION 3 0.0007
322 FEAR OF INJECTION 5 0.0007
323 PRODUCT USE COMPLAINT 11 0.0007
324 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
325 TONGUE DISORDER 5 0.0007
326 BILIARY COLIC 2 0.0007
327 NEEDLE ISSUE 20 0.0007
328 NECK INJURY 2 0.0007
329 STRIDOR 2 0.0007
330 RHINITIS ALLERGIC 3 0.0007
331 ANGIOPLASTY 1 0.0007
332 ROAD TRAFFIC ACCIDENT 28 0.0007
333 HYPERCAPNIA 2 0.0007
334 ASTIGMATISM 1 0.0007
335 IMMUNE THROMBOCYTOPENIA 3 0.0007
336 DYSCHEZIA 2 0.0007
337 INJECTION SITE REACTION 45 0.0007
338 ECTOPIC PREGNANCY 2 0.0006
339 LOCALISED OEDEMA 3 0.0006
340 GASTROINTESTINAL INFLAMMATION 5 0.0006
341 BREAST CANCER RECURRENT 2 0.0006
342 VIRAL INFECTION 21 0.0006
343 BLADDER PAIN 2 0.0006
344 ENDOMETRIOSIS 3 0.0006
345 GASTROENTERITIS 9 0.0006
346 CONDITION AGGRAVATED 187 0.0006
347 HORMONE LEVEL ABNORMAL 3 0.0006
348 PANCREATIC DISORDER 3 0.0006
349 EXPIRED DEVICE USED 2 0.0006
350 APPLICATION SITE SWELLING 3 0.0006
351 EAR INFECTION 16 0.0006
352 INJECTION SITE SWELLING 46 0.0006
353 COVID-19 105 0.0006
354 PLANTAR FASCIITIS 2 0.0006
355 CEREBELLAR INFARCTION 1 0.0006
356 HEPATIC CYST 2 0.0006
357 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
358 CERVICAL VERTEBRAL FRACTURE 2 0.0006
359 BREAST DISCHARGE 1 0.0006
360 JOINT DISLOCATION 6 0.0006
361 BREAST CYST 1 0.0006
362 OBESITY 9 0.0006
363 PHARYNGITIS 7 0.0006
364 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
365 NO ADVERSE EVENT 102 0.0006
366 PRODUCT SUPPLY ISSUE 4 0.0006
367 GASTROINTESTINAL INFECTION 5 0.0006
368 BRAIN OEDEMA 7 0.0006
369 TOOTHACHE 10 0.0006
370 INJECTION SITE BRUISING 44 0.0006
371 SENSITIVE SKIN 4 0.0005
372 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
373 PSYCHIATRIC SYMPTOM 4 0.0005
374 WOUND HAEMORRHAGE 2 0.0005
375 PROCEDURAL PAIN 15 0.0005
376 ABORTION INCOMPLETE 1 0.0005
377 BLADDER SPASM 1 0.0005
378 BLOOD IRON INCREASED 1 0.0005
379 GASTRITIS 14 0.0005
380 TOOTH INFECTION 7 0.0005
381 SPINAL DISORDER 5 0.0005
382 DERMATITIS CONTACT 6 0.0005
383 MUSCULOSKELETAL CHEST PAIN 8 0.0005
384 INJECTION SITE ERYTHEMA 64 0.0005
385 SYRINGE ISSUE 9 0.0005
386 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
387 CERVIX CARCINOMA 2 0.0005
388 SINUSITIS 52 0.0005
389 PNEUMONIA FUNGAL 2 0.0005
390 OESOPHAGEAL PAIN 2 0.0005
391 CELL DEATH 1 0.0005
392 INFLAMMATION 26 0.0005
393 BLADDER DISORDER 5 0.0005
394 MIGRAINE 48 0.0005
395 ACCIDENT 6 0.0005
396 EXPOSURE VIA BREAST MILK 2 0.0005
397 LOCALISED INFECTION 12 0.0005
398 TOOTH DISORDER 11 0.0005
399 INGUINAL HERNIA 3 0.0005
400 TOOTH ABSCESS 5 0.0005
401 CHANGE OF BOWEL HABIT 1 0.0005
402 BRONCHITIS 36 0.0005
403 SWELLING OF EYELID 3 0.0005
404 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
405 PRODUCT USE IN UNAPPROVED INDICATION 118 0.0005
406 FOOT FRACTURE 9 0.0005
407 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
408 SCRATCH 5 0.0005
409 LIP OEDEMA 2 0.0005
410 ABSCESS LIMB 2 0.0005
411 POST PROCEDURAL COMPLICATION 9 0.0005
412 JOINT INJURY 10 0.0005
413 PRODUCT CONTAINER ISSUE 4 0.0005
414 INJECTION SITE PAIN 143 0.0005
415 ABSCESS INTESTINAL 1 0.0005
416 HEPATIC LESION 2 0.0005
417 PHARYNGITIS STREPTOCOCCAL 5 0.0005
418 HYSTERECTOMY 4 0.0005
419 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
420 POLYP 3 0.0005
421 CERVICAL DYSPLASIA 1 0.0005
422 DIVERTICULUM INTESTINAL 2 0.0005
423 BIPOLAR I DISORDER 1 0.0005
424 SARS-COV-2 TEST POSITIVE 6 0.0005
425 ANGIOEDEMA 20 0.0005
426 LIP SWELLING 15 0.0004
427 METASTASES TO LYMPH NODES 3 0.0004
428 ILL-DEFINED DISORDER 27 0.0004
429 SUSPECTED OFF LABEL USE 2 0.0004
430 BRAIN OPERATION 1 0.0004
431 RESPIRATION ABNORMAL 3 0.0004
432 NERVE COMPRESSION 4 0.0004
433 SYNOVIAL CYST 2 0.0004
434 EYE SWELLING 16 0.0004
435 APHONIA 6 0.0004
436 POST PROCEDURAL HAEMORRHAGE 5 0.0004
437 MASS 6 0.0004
438 SPINAL PAIN 5 0.0004
439 INTESTINAL OBSTRUCTION 16 0.0004
440 PRE-ECLAMPSIA 2 0.0004
441 WRIST FRACTURE 5 0.0004
442 ANAPHYLACTIC REACTION 23 0.0004
443 VULVOVAGINAL PAIN 2 0.0004
444 CRYING 15 0.0004
445 NEURALGIA 10 0.0004
446 PRODUCT STORAGE ERROR 36 0.0004
447 FEAR 11 0.0004
448 THERAPY INTERRUPTED 29 0.0004
449 STAPHYLOCOCCAL SEPSIS 2 0.0004
450 PERIPHERAL SWELLING 62 0.0004
451 ILEUS 5 0.0004
452 PROTEIN URINE PRESENT 2 0.0004
453 RESPIRATORY DISORDER 12 0.0004
454 URTICARIA 67 0.0004
455 SALIVARY HYPERSECRETION 4 0.0004
456 DEPRESSED MOOD 21 0.0004
457 HEAD DISCOMFORT 7 0.0004
458 BRAIN ABSCESS 1 0.0004
459 DYSPHONIA 23 0.0004
460 PHLEBITIS 2 0.0004
461 PHARYNGEAL OEDEMA 6 0.0004
462 LYMPHOMA 6 0.0004
463 LIMB DISCOMFORT 12 0.0004
464 EXPOSURE DURING PREGNANCY 24 0.0004
465 FAILURE TO THRIVE 2 0.0004
466 BURNING SENSATION 27 0.0004
467 UNDERDOSE 28 0.0004
468 BRAIN FOG 6 0.0004
469 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
470 AFFECTIVE DISORDER 3 0.0004
471 INJECTION SITE DISCOMFORT 4 0.0004
472 HEAD INJURY 12 0.0004
473 PNEUMOTHORAX 6 0.0004
474 CYSTITIS 12 0.0004
475 ALCOHOL ABUSE 1 0.0004
476 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
477 POOR QUALITY SLEEP 8 0.0004
478 HIP SURGERY 2 0.0004
479 POST PROCEDURAL INFECTION 3 0.0004
480 ABDOMINAL RIGIDITY 1 0.0004
481 ASPHYXIA 3 0.0004
482 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
483 APPLICATION SITE HAEMORRHAGE 1 0.0004
484 GASTROINTESTINAL PAIN 4 0.0004
485 CHOKING SENSATION 2 0.0004
486 EAR PAIN 7 0.0004
487 INFECTION 52 0.0004
488 ABDOMINAL PAIN LOWER 9 0.0004
489 COLECTOMY 2 0.0004
490 SINUS DISORDER 7 0.0004
491 CEREBRAL THROMBOSIS 1 0.0004
492 RESPIRATORY TRACT INFECTION 9 0.0003
493 FEEDING DISORDER 7 0.0003
494 DISCOMFORT 21 0.0003
495 SKIN WARM 2 0.0003
496 NASAL CONGESTION 20 0.0003
497 RIB FRACTURE 7 0.0003
498 ABDOMINAL PAIN 79 0.0003
499 BLOOD IRON DECREASED 4 0.0003
500 PLEURISY 2 0.0003
501 ASTHMA 38 0.0003
502 PULMONARY MASS 5 0.0003
503 THROMBOSIS 27 0.0003
504 ODYNOPHAGIA 2 0.0003
505 ACNE CYSTIC 1 0.0003
506 INJECTION SITE VESICLES 2 0.0003
507 INJECTION SITE PRURITUS 22 0.0003
508 INJECTION SITE RASH 10 0.0003
509 SPINAL OPERATION 4 0.0003
510 THINKING ABNORMAL 6 0.0003
511 INFUSION SITE EXTRAVASATION 2 0.0003
512 APPENDICITIS 3 0.0003
513 DERMATITIS ALLERGIC 4 0.0003
514 INFUSION SITE SWELLING 2 0.0003
515 ADVERSE EVENT 29 0.0003
516 SCIATICA 5 0.0003
517 HYPOTHYROIDISM 10 0.0003
518 HAEMOGLOBIN ABNORMAL 2 0.0003
519 HERNIA 6 0.0003
520 INJECTION SITE INDURATION 4 0.0003
521 AUTOIMMUNE DISORDER 3 0.0003
522 BACK DISORDER 5 0.0003
523 IMMUNE SYSTEM DISORDER 4 0.0003
524 WALKING AID USER 2 0.0003
525 BLOOD PRESSURE ABNORMAL 6 0.0003
526 HEADACHE 188 0.0003
527 BREAST MASS 2 0.0003
528 POSTOPERATIVE WOUND INFECTION 2 0.0003
529 VERTIGO 18 0.0003
530 B-CELL LYMPHOMA 1 0.0003
531 GINGIVAL BLEEDING 4 0.0003
532 EAR DISCOMFORT 3 0.0003
533 MALAISE 128 0.0003
534 ECCHYMOSIS 2 0.0003
535 INFLUENZA LIKE ILLNESS 24 0.0003
536 JOINT EFFUSION 2 0.0003
537 DROOLING 2 0.0003
538 URINARY TRACT INFECTION 49 0.0003
539 BLINDNESS UNILATERAL 4 0.0003
540 HAND FRACTURE 2 0.0003
541 NASOPHARYNGITIS 52 0.0003
542 BREAST PAIN 3 0.0003
543 MATERNAL EXPOSURE DURING PREGNANCY 25 0.0003
544 APPENDICECTOMY 1 0.0003
545 PANIC REACTION 2 0.0003
546 CHEST PAIN 51 0.0003
547 PULMONARY THROMBOSIS 3 0.0003
548 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
549 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
550 CAROTID ARTERY OCCLUSION 1 0.0003
551 APPLICATION SITE PAIN 6 0.0003
552 TOOTH FRACTURE 3 0.0003
553 BLINDNESS TRANSIENT 2 0.0003
554 OROPHARYNGEAL PAIN 25 0.0003
555 CARDIAC DYSFUNCTION 1 0.0003
556 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
557 FALL 88 0.0003
558 INTERNAL HAEMORRHAGE 3 0.0003
559 FEELING JITTERY 5 0.0003
560 HIP ARTHROPLASTY 4 0.0003
561 PROCEDURAL COMPLICATION 2 0.0003
562 CONTUSION 25 0.0003
563 METASTASES TO LUNG 3 0.0003
564 ANKLE FRACTURE 4 0.0003
565 EYELID OEDEMA 3 0.0003
566 BASAL CELL CARCINOMA 4 0.0003
567 DEHYDRATION 34 0.0003
568 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
569 COVID-19 PNEUMONIA 3 0.0003
570 CHEST DISCOMFORT 26 0.0003
571 MENTAL DISORDER 11 0.0003
572 UPPER LIMB FRACTURE 5 0.0003
573 PRESCRIBED UNDERDOSE 5 0.0003
574 SYNCOPE 25 0.0002
575 ARTERIOSPASM CORONARY 1 0.0002
576 HYPERSENSITIVITY 46 0.0002
577 PNEUMONIA 80 0.0002
578 APPLICATION SITE DISCOLOURATION 1 0.0002
579 LUNG DISORDER 12 0.0002
580 ABNORMAL FAECES 2 0.0002
581 INJECTION SITE MASS 9 0.0002
582 PRODUCT PREPARATION ERROR 5 0.0002
583 INJECTION SITE EXTRAVASATION 3 0.0002
584 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
585 MUSCLE INJURY 2 0.0002
586 INJECTION SITE DISCOLOURATION 3 0.0002
587 GAIT INABILITY 8 0.0002
588 HEPATIC CYTOLYSIS 3 0.0002
589 CATARACT 14 0.0002
590 AORTIC VALVE INCOMPETENCE 1 0.0002
591 FACIAL PARALYSIS 2 0.0002
592 SCAR 4 0.0002
593 ROTATOR CUFF SYNDROME 3 0.0002
594 PSEUDOMONAS INFECTION 2 0.0002
595 MUSCULOSKELETAL DISCOMFORT 4 0.0002
596 HAEMATOMA 6 0.0002
597 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
598 PRODUCTIVE COUGH 11 0.0002
599 RASH MACULAR 8 0.0002
600 URINE OUTPUT DECREASED 2 0.0002
601 BEDRIDDEN 3 0.0002
602 GROIN PAIN 2 0.0002
603 ABDOMINAL ABSCESS 1 0.0002
604 HERPES ZOSTER 13 0.0002
605 DRUG INEFFECTIVE 298 0.0002
606 GALLBLADDER DISORDER 4 0.0002
607 MENSTRUATION IRREGULAR 6 0.0002
608 BRAIN NEOPLASM MALIGNANT 1 0.0002
609 HAEMARTHROSIS 2 0.0002
610 SINUS CONGESTION 3 0.0002
611 IMPAIRED GASTRIC EMPTYING 3 0.0002
612 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
613 ABDOMINAL HERNIA 1 0.0002
614 WHEEZING 13 0.0002
615 DYSURIA 8 0.0002
616 RHINORRHOEA 14 0.0002
617 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
618 NECK PAIN 12 0.0002
619 DIARRHOEA HAEMORRHAGIC 2 0.0002
620 CARDIAC DISORDER 20 0.0002
621 EYE DISORDER 7 0.0002
622 STAPHYLOCOCCAL INFECTION 7 0.0002
623 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
624 MUSCULOSKELETAL DISORDER 4 0.0002
625 SLEEP APNOEA SYNDROME 4 0.0002
626 ABDOMINAL PAIN UPPER 43 0.0002
627 ABDOMINAL DISCOMFORT 35 0.0002
628 PARAESTHESIA ORAL 3 0.0002
629 AFFECT LABILITY 2 0.0002
630 SEIZURE 24 0.0002
631 ANOSMIA 3 0.0002
632 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
633 PRESYNCOPE 5 0.0002
634 KNEE OPERATION 2 0.0002
635 BODY TEMPERATURE DECREASED 2 0.0002
636 COLON CANCER 3 0.0002
637 ANEURYSM 1 0.0002
638 THROAT IRRITATION 9 0.0002
639 BRAIN INJURY 2 0.0002
640 HYPOAESTHESIA ORAL 3 0.0002
641 PAIN 122 0.0002
642 PRODUCT ADMINISTRATION ERROR 4 0.0002
643 ARTHROPATHY 11 0.0002
644 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
645 ANXIETY 56 0.0002
646 BLINDNESS 8 0.0002
647 BLOOD PRESSURE DECREASED 13 0.0002
648 HOSPITALISATION 30 0.0002
649 DYSPNOEA 109 0.0002
650 HEART RATE INCREASED 19 0.0002
651 NERVOUSNESS 10 0.0002
652 TACHYCARDIA 17 0.0002
653 RENAL PAIN 2 0.0002
654 DIZZINESS 94 0.0002
655 SEPSIS 21 0.0002
656 ANORECTAL DISCOMFORT 1 0.0002
657 EATING DISORDER 4 0.0002
658 INJECTION SITE HAEMORRHAGE 15 0.0002
659 CHILLS 22 0.0002
660 SURGERY 11 0.0002
661 MOVEMENT DISORDER 6 0.0002
662 ANAL ABSCESS 1 0.0002
663 BRUXISM 1 0.0002
664 COUGH 52 0.0002
665 PYREXIA 64 0.0002
666 INJURY 13 0.0002
667 THROAT TIGHTNESS 5 0.0002
668 CHEILITIS 1 0.0002
669 PALLOR 5 0.0002
670 VOMITING 86 0.0002
671 HAEMORRHAGE 19 0.0002
672 RESPIRATORY DISTRESS 5 0.0002
673 ABNORMAL DREAMS 5 0.0002
674 DENTAL CARIES 2 0.0002
675 BACK PAIN 42 0.0002
676 DIVERTICULITIS 5 0.0002
677 URINARY RETENTION 6 0.0002
678 NEOPLASM MALIGNANT 12 0.0002
679 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
680 FEELING COLD 5 0.0002
681 LOSS OF CONSCIOUSNESS 23 0.0002
682 DEVICE ISSUE 16 0.0002
683 FACE OEDEMA 3 0.0002
684 EYE PAIN 10 0.0002
685 EYE INFECTION 2 0.0002
686 FLUID RETENTION 9 0.0002
687 FEELING ABNORMAL 42 0.0002
688 CARDIAC VALVE DISEASE 1 0.0002
689 ABORTION SPONTANEOUS 7 0.0002
690 NEOPLASM 2 0.0002
691 GASTRIC HAEMORRHAGE 2 0.0002
692 HYPOAESTHESIA 26 0.0002
693 BLOOD URIC ACID INCREASED 1 0.0002
694 DEVICE DEFECTIVE 3 0.0002
695 VASCULITIS 2 0.0002
696 SPLENOMEGALY 2 0.0002
697 COLD SWEAT 3 0.0002
698 CHOLECYSTITIS 2 0.0002
699 CARDIAC PACEMAKER INSERTION 1 0.0002
700 HYPERLIPIDAEMIA 2 0.0002
701 MOBILITY DECREASED 12 0.0002
702 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
703 BLOOD POTASSIUM DECREASED 5 0.0002
704 RASH PRURITIC 9 0.0002
705 INFUSION RELATED REACTION 11 0.0002
706 EPILEPSY 5 0.0002
707 BLOOD PRESSURE INCREASED 25 0.0002
708 PALPITATIONS 19 0.0002
709 GENERALISED OEDEMA 2 0.0002
710 CYST 2 0.0002
711 NERVOUS SYSTEM DISORDER 5 0.0002
712 OXYGEN SATURATION DECREASED 9 0.0002
713 SECRETION DISCHARGE 2 0.0002
714 ASTHENIA 60 0.0002
715 BLEPHAROSPASM 1 0.0002
716 MYALGIA 27 0.0002
717 MUSCULAR WEAKNESS 18 0.0002
718 COLITIS 6 0.0002
719 BLOOD URINE PRESENT 3 0.0002
720 GASTRIC ULCER 3 0.0002
721 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
722 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
723 THERAPY CESSATION 8 0.0002
724 GLAUCOMA 3 0.0002
725 ANAPHYLACTIC SHOCK 4 0.0002
726 CARDIAC FLUTTER 1 0.0002
727 DYSTONIA 3 0.0002
728 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
729 DEPRESSION 35 0.0002
730 PRODUCT DOSE OMISSION 10 0.0002
731 SPEECH DISORDER 8 0.0002
732 CHOLELITHIASIS 5 0.0002
733 ORAL CANDIDIASIS 2 0.0002
734 ANKYLOSING SPONDYLITIS 2 0.0002
735 EYE HAEMORRHAGE 2 0.0001
736 PAIN IN EXTREMITY 44 0.0001
737 JOINT SWELLING 18 0.0001
738 NAUSEA 118 0.0001
739 QUALITY OF LIFE DECREASED 2 0.0001
740 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
741 FREQUENT BOWEL MOVEMENTS 4 0.0001
742 TASTE DISORDER 3 0.0001
743 DYSPHAGIA 14 0.0001
744 INJURY ASSOCIATED WITH DEVICE 3 0.0001
745 BODY TEMPERATURE INCREASED 3 0.0001
746 MOOD ALTERED 4 0.0001
747 RASH ERYTHEMATOUS 7 0.0001
748 INJECTION SITE WARMTH 3 0.0001
749 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
750 APPLICATION SITE RASH 2 0.0001
751 UNEVALUABLE EVENT 11 0.0001
752 SOMNOLENCE 29 0.0001
753 ORAL DISCOMFORT 2 0.0001
754 WOUND 4 0.0001
755 DEVICE OCCLUSION 2 0.0001
756 INTENTIONAL DOSE OMISSION 4 0.0001
757 IRRITABLE BOWEL SYNDROME 3 0.0001
758 LIVER FUNCTION TEST INCREASED 3 0.0001
759 PARALYSIS 2 0.0001
760 DIARRHOEA 90 0.0001
761 OFF LABEL USE 122 0.0001
762 IMPAIRED QUALITY OF LIFE 2 0.0001
763 CELLULITIS 7 0.0001
764 FAECES DISCOLOURED 3 0.0001
765 HYPOKINESIA 2 0.0001
766 PANIC ATTACK 5 0.0001
767 BONE PAIN 8 0.0001
768 ERYTHEMA 28 0.0001
769 INCORRECT DOSE ADMINISTERED 31 0.0001
770 INSOMNIA 36 0.0001
771 TRANSAMINASES INCREASED 3 0.0001
772 THERAPY NON-RESPONDER 6 0.0001
773 BREAST TENDERNESS 1 0.0001
774 DYSPNOEA EXERTIONAL 5 0.0001
775 PRURITUS 51 0.0001
776 ECONOMIC PROBLEM 2 0.0001
777 FATIGUE 102 0.0001
778 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
779 TENDONITIS 2 0.0001
780 APHTHOUS ULCER 1 0.0001
781 RENAL DISORDER 6 0.0001
782 PULMONARY EMBOLISM 12 0.0001
783 ULCER 2 0.0001
784 BLOOD DISORDER 1 0.0001
785 SENSORY DISTURBANCE 2 0.0001
786 HYPERHIDROSIS 16 0.0001
787 CEREBROVASCULAR ACCIDENT 21 0.0001
788 RASH 54 0.0001
789 VISION BLURRED 17 0.0001
790 CONSTIPATION 27 0.0001
791 MEMORY IMPAIRMENT 17 0.0001
792 FIBROMYALGIA 3 0.0001
793 ARTHRALGIA 51 0.0001
794 ADVERSE DRUG REACTION 11 0.0001
795 ALOPECIA 24 0.0001
796 OSTEONECROSIS 4 0.0001
797 PHOTOSENSITIVITY REACTION 2 0.0001
798 EPISTAXIS 9 0.0001
799 AGEUSIA 3 0.0001
800 SKIN DISORDER 4 0.0001
801 EYE PRURITUS 4 0.0001
802 ACNE 9 0.0001
803 BREAST CANCER 11 0.0001
804 HEPATITIS 3 0.0001
805 RECTAL HAEMORRHAGE 5 0.0001
806 CARDIAC OPERATION 1 0.0001
807 DECREASED APPETITE 27 0.0001
808 BLOOD MAGNESIUM DECREASED 1 0.0001
809 CARDIAC MURMUR 1 0.0001
810 VAGINAL HAEMORRHAGE 5 0.0001
811 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
812 APPLICATION SITE ERYTHEMA 3 0.0001
813 MUSCLE SPASMS 21 0.0001
814 ARTHRITIS 9 0.0001
815 DEVICE USE ISSUE 2 0.0001
816 AMENORRHOEA 2 0.0001
817 PANCREATITIS 6 0.0001
818 DRUG ERUPTION 2 0.0001
819 LIVER DISORDER 5 0.0001
820 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
821 DYSPEPSIA 11 0.0001
822 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
823 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
824 OEDEMA 6 0.0001
825 PELVIC PAIN 2 0.0001
826 RESTLESS LEGS SYNDROME 2 0.0001
827 BONE DISORDER 2 0.0001
828 GAIT DISTURBANCE 21 0.0001
829 BRAIN NEOPLASM 1 0.0001
830 TINNITUS 5 0.0001
831 PARAESTHESIA 17 0.0001
832 CONJUNCTIVITIS 2 0.0001
833 ARTERIOSCLEROSIS 1 0.0001
834 FLATULENCE 6 0.0001
835 HYPERSOMNIA 3 0.0001
836 HYPERTENSION 22 0.0001
837 DYSSTASIA 3 0.0001
838 HEPATIC ENZYME INCREASED 7 0.0001
839 TREMOR 17 0.0001
840 DISORIENTATION 4 0.0001
841 SPINAL FRACTURE 2 0.0001
842 PRODUCT PHYSICAL ISSUE 2 0.0001
843 INTENTIONAL SELF-INJURY 2 0.0001
844 DYSKINESIA 4 0.0001
845 PERITONITIS 2 0.0001
846 TOOTH LOSS 2 0.0001
847 POLLAKIURIA 4 0.0001
848 ECZEMA 5 0.0001
849 DERMATITIS 2 0.0001
850 MOUTH ULCERATION 2 0.0001
851 MOOD SWINGS 3 0.0001
852 SKIN CANCER 2 0.0001
853 BALANCE DISORDER 8 0.0001
854 BACK INJURY 1 0.0001
855 PRODUCT DISPENSING ERROR 2 0.0001
856 MUSCULOSKELETAL STIFFNESS 8 0.0001
857 ASPIRATION 1 0.0001
858 BLOOD GLUCOSE FLUCTUATION 1 0.0001
859 FUNGAL INFECTION 3 0.0001
860 GLOSSODYNIA 2 0.0001
861 ORAL PAIN 2 0.0001
862 SNEEZING 2 0.0001
863 BLISTER 5 0.0001
864 CHROMATURIA 2 0.0001
865 FLUSHING 9 0.0001
866 APPLICATION SITE PRURITUS 2 0.0001
867 HAEMOGLOBIN DECREASED 9 0.0001
868 SKIN DISCOLOURATION 4 0.0001
869 SHOCK 2 0.0001
870 NIGHTMARE 3 0.0001
871 PERICARDIAL EFFUSION 2 0.0001
872 OCULAR HYPERAEMIA 4 0.0001
873 ATAXIA 1 0.0001
874 BACTERAEMIA 1 0.0001
875 MULTIPLE SCLEROSIS 4 0.0001
876 BLOOD PRESSURE FLUCTUATION 2 0.0001
877 DRUG EFFECT INCOMPLETE 3 0.0001
878 SUICIDE ATTEMPT 5 0.0001
879 ADRENAL INSUFFICIENCY 1 0.0001
880 LIVER INJURY 2 0.0001
881 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
882 MYOCARDIAL INFARCTION 14 0.0001
883 DRY EYE 4 0.0001
884 AGGRESSION 4 0.0001
885 GASTRIC CANCER 2 0.0001
886 ERECTILE DYSFUNCTION 2 0.0001
887 DRUG RESISTANCE 2 0.0001
888 UNRESPONSIVE TO STIMULI 2 0.0001
889 BRADYCARDIA 4 0.0001
890 ADVERSE REACTION 1 0.0001
891 BREAST CANCER FEMALE 2 0.0001
892 PAIN OF SKIN 2 0.0001
893 OEDEMA PERIPHERAL 9 0.0001
894 OSTEOPOROSIS 3 0.0001
895 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
896 VISUAL IMPAIRMENT 9 0.0001
897 RESPIRATORY ARREST 2 0.0001
898 HAEMATOCHEZIA 4 0.0001
899 MENTAL STATUS CHANGES 2 0.0001
900 CARDIO-RESPIRATORY ARREST 3 0.0001
901 HAEMOPTYSIS 2 0.0001
902 DEMENTIA 2 0.0001
903 CARPAL TUNNEL SYNDROME 1 0.0001
904 PAIN IN JAW 2 0.0001
905 RHEUMATOID ARTHRITIS 8 0.0001
906 BRONCHOSPASM 1 0.0001
907 LETHARGY 4 0.0001
908 ACCIDENTAL UNDERDOSE 1 0.0001
909 DEVICE DISLOCATION 3 0.0001
910 APATHY 1 0.0001
911 PSYCHOTIC DISORDER 2 0.0001
912 IRRITABILITY 4 0.0001
913 APHASIA 2 0.0001
914 SUICIDAL IDEATION 6 0.0001
915 FEMUR FRACTURE 2 0.0001
916 ANAEMIA 12 0.0001
917 ABSCESS 1 0.0001
918 BLOOD GLUCOSE DECREASED 3 0.0001
919 HIP FRACTURE 2 0.0001
920 NIGHT SWEATS 2 0.0001
921 ATRIAL FIBRILLATION 6 0.0001
922 DEEP VEIN THROMBOSIS 4 0.0001
923 AMNESIA 4 0.0001
924 IMPAIRED HEALING 2 0.0001
925 LEUKOPENIA 3 0.0001
926 TYPE 2 DIABETES MELLITUS 2 0.0001
927 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
928 ANGER 2 0.0001
929 HAEMATURIA 2 0.0001
930 GASTRIC DISORDER 2 0.0001
931 INTENTIONAL PRODUCT MISUSE 5 0.0001
932 HEART RATE DECREASED 2 0.0001
933 DEVICE MALFUNCTION 4 0.0001
934 DERMATITIS ATOPIC 3 0.0001
935 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
936 LYMPHADENOPATHY 2 0.0001
937 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
938 RESPIRATORY FAILURE 4 0.0001
939 HYPOTENSION 11 0.0001
940 BLOOD GLUCOSE ABNORMAL 1 0.0001
941 BACTERIAL INFECTION 1 0.0001
942 HEPATIC FUNCTION ABNORMAL 2 0.0001
943 BLOOD SODIUM DECREASED 1 0.0001
944 NEUROPATHY PERIPHERAL 5 0.0001
945 PRODUCT QUALITY ISSUE 7 0.0001
946 PLASMA CELL MYELOMA 2 0.0001
947 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
948 EMOTIONAL DISTRESS 6 0.0000
949 STOMATITIS 3 0.0000
950 DRY MOUTH 4 0.0000
951 FEELING HOT 3 0.0000
952 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
953 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
954 DEVICE LEAKAGE 2 0.0000
955 PULMONARY OEDEMA 2 0.0000
956 SKIN IRRITATION 2 0.0000
957 HYPOKALAEMIA 2 0.0000
958 CONFUSIONAL STATE 7 0.0000
959 BLOOD CHOLESTEROL INCREASED 2 0.0000
960 COGNITIVE DISORDER 2 0.0000
961 SLEEP DISORDER 3 0.0000
962 ARRHYTHMIA 2 0.0000
963 COMA 2 0.0000
964 SKIN BURNING SENSATION 3 0.0000
965 INTERSTITIAL LUNG DISEASE 2 0.0000
966 AGITATION 3 0.0000
967 PROSTATE CANCER 3 0.0000
968 BLOOD GLUCOSE INCREASED 7 0.0000
969 MEDICATION ERROR 2 0.0000
970 SKIN EXFOLIATION 3 0.0000
971 ANGINA PECTORIS 1 0.0000
972 PRODUCT SUBSTITUTION ISSUE 2 0.0000
973 ASCITES 1 0.0000
974 ACUTE MYOCARDIAL INFARCTION 1 0.0000
975 THERAPEUTIC RESPONSE DECREASED 2 0.0000
976 DEATH 27 0.0000
977 DRUG INTOLERANCE 3 0.0000
978 DEVICE DIFFICULT TO USE 2 0.0000
979 DRY SKIN 4 0.0000
980 OVERDOSE 6 0.0000
981 DYSGEUSIA 2 0.0000
982 HALLUCINATION 2 0.0000
983 ABNORMAL BEHAVIOUR 1 0.0000
984 TREATMENT FAILURE 2 0.0000
985 COMPLETED SUICIDE 2 0.0000
986 RENAL IMPAIRMENT 2 0.0000
987 PLATELET COUNT DECREASED 2 0.0000
988 DISEASE PROGRESSION 2 0.0000
989 BLOOD CREATININE INCREASED 1 0.0000
990 RENAL FAILURE 2 0.0000
991 CARDIAC FAILURE 1 0.0000
992 CARDIAC FAILURE CONGESTIVE 1 0.0000
993 DRUG DEPENDENCE 2 0.0000
994 CARDIAC ARREST 1 0.0000